Starpharma Holdings Ltd has released a press release.
FDA confirms path to DEP HER2 first-in-human study
Earlier from Starpharma
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- AGM Chair address and CEO presentation
- Upfront payment of USD $5.5 million received from Genentech